<!DOCTYPE html>

<html lang="en" data-theme="light">
<head>
<meta charset="UTF-8">
<meta name="viewport" content="width=device-width, initial-scale=1.0">
<title>Anticholinergic Drugs - Essentials of Medical Pharmacology</title>
<link rel="preconnect" href="https://fonts.googleapis.com">
<link rel="preconnect" href="https://fonts.gstatic.com" crossorigin>
<link href="https://fonts.googleapis.com/css2?family=Inter:wght@400;500;600;700&family=Source+Serif+4:opsz,wght@8..60,400;8..60,600&display=swap" rel="stylesheet">

<link rel="stylesheet" href="../styles/main.css">

<script>
MathJax = {
    tex: {
        inlineMath: [['$', '$'], ['\\(', '\\)']],
        displayMath: [['$$', '$$'], ['\\[', '\\]']],
        processEscapes: true,
        processEnvironments: true
    },
    svg: { fontCache: 'global' },
    options: {
        skipHtmlTags: ['script', 'noscript', 'style', 'textarea', 'pre']
    }
};
</script>
<script id="MathJax-script" async src="https://cdn.jsdelivr.net/npm/mathjax@3/es5/tex-mml-chtml.js"></script>
</head>
<body>
<a href="#main-content" class="skip-link">Skip to main content</a>

<button class="theme-toggle" id="theme-toggle" aria-label="Toggle dark mode">
    <span class="theme-toggle-icon light-icon">‚òÄÔ∏è</span>
    <span class="theme-toggle-icon dark-icon">üåô</span>
</button>

<div class="reading-progress-container">
    <div class="reading-progress-bar" id="reading-progress"></div>
</div>

<!-- Floating TOC -->
<nav class="floating-toc" id="floating-toc">
    <div class="floating-toc-header">
        <span>üìë</span> Table of Contents
    </div>
    <ul class="floating-toc-list">
        <li><a href="#atropine-actions">Atropine: Actions</a></li>
        <li><a href="#atropine-hyoscine">Atropine vs Hyoscine</a></li>
        <li><a href="#substitutes">Atropine Substitutes</a></li>
        <li><a href="#uses">Therapeutic Uses</a></li>
        <li><a href="#toxicity">Toxicity & Poisoning</a></li>
        <li><a href="#ganglionic-drugs">Ganglionic Drugs</a></li>
        <li><a href="#problem-study">Problem Directed Study</a></li>
    </ul>
</nav>

<div class="page-wrapper">
    <div class="container">
        <article class="document-article">
            <header class="document-header">
                <div class="header-badge">
                    <span>üçÑ</span>
                    <span>Topic 09</span>
                </div>
                <h1 class="document-title">Anticholinergic Drugs</h1>
                <div class="title-meta">
                    <div class="meta-item">
                        <span>üìö</span>
                        <span>Drugs Acting on ANS</span>
                    </div>
                    <div class="meta-item">
                        <span>‚è±Ô∏è</span>
                        <span>35 min read</span>
                    </div>
                </div>
            </header>

            <main id="main-content" class="content-wrapper">
                <!-- Section 1: Introduction & Atropine -->
                <section class="content-section" id="atropine-actions">
                    <div class="section-header">
                        <div class="section-number">01</div>
                        <h2 class="section-title">
                            <span class="title-icon">üõë</span>
                            Muscarinic Receptor Antagonists
                        </h2>
                    </div>

                    <div class="content-card">
                        <p>Conventionally, the term 'anticholinergic drugs' is restricted to those which block actions of ACh on autonomic effectors and in the CNS exerted through muscarinic receptors. They are competitive antagonists. <strong>Atropine</strong>, the prototype drug of this class, is highly selective for muscarinic receptors.</p>

                        <h3>Pharmacological Actions (Atropine as Prototype)</h3>
                        <p>The actions of atropine can be largely predicted from knowledge of parasympathetic responses. Prominent effects are seen in organs which normally receive strong parasympathetic tone.</p>

                        <div class="grid grid-2">
                            <div class="grid-item">
                                <h4>1. CNS</h4>
                                <p>Atropine has an overall CNS stimulant action (high doses). Stimulates medullary centres (vagal, respiratory, vasomotor). Suppresses tremor/rigidity (Parkinsonism) and vestibular excitation (motion sickness).</p>
                            </div>
                            <div class="grid-item">
                                <h4>2. CVS</h4>
                                <p><strong>Heart:</strong> Tachycardia due to blockade of $M_2$ receptors on SA node. Facilitates A-V conduction.<br><strong>BP:</strong> No consistent effect, but blocks vasodepressor action of cholinergic agonists.</p>
                            </div>
                            <div class="grid-item">
                                <h4>3. Eye</h4>
                                <p>Mydriasis (pupil dilation), abolition of light reflex, and cycloplegia (paralysis of accommodation). IOP tends to rise, especially in narrow angle glaucoma.</p>
                            </div>
                            <div class="grid-item">
                                <h4>4. Smooth Muscles</h4>
                                <p>Relaxation of all visceral smooth muscles (stomach, intestine, bladder, bronchi). Constipation, urinary retention, bronchodilatation.</p>
                            </div>
                            <div class="grid-item">
                                <h4>5. Glands</h4>
                                <p>Marked decrease in sweat, salivary, tracheobronchial and lacrimal secretion ($M_3$ blockade). Skin/eyes become dry, talking/swallowing difficult. Gastric acid reduced but less efficacious than $H_2$ blockers.</p>
                            </div>
                            <div class="grid-item">
                                <h4>6. Body Temperature</h4>
                                <p>Rise in body temperature (Atropine fever), especially in children, due to inhibition of sweating and stimulation of temperature regulating centre.</p>
                            </div>
                        </div>

                        <figure class="content-figure" data-lightbox="true">
                            <div class="figure-image-wrapper">
                                <img src="../assets/images/image-20251214-a08235c6.jpeg" alt="Autonomic control of pupil and site of action of mydriatics and miotics" class="figure-image">
                                <div class="figure-overlay">
                                    <span class="overlay-icon">üîç</span>
                                    <span class="overlay-text">Click to enlarge</span>
                                </div>
                            </div>
                            <figcaption class="figure-caption">Fig. 8.1: Autonomic control of pupil (A); and site of action of mydriatics (B) and miotics (C).</figcaption>
                        </figure>
                    </div>
                </section>

                <!-- Section 2: Comparison -->
                <section class="content-section" id="atropine-hyoscine">
                    <div class="section-header">
                        <div class="section-number">02</div>
                        <h2 class="section-title">
                            <span class="title-icon">‚öñÔ∏è</span>
                            Atropine vs Hyoscine
                        </h2>
                    </div>

                    <div class="content-card">
                        <div class="table-responsive">
                            <table class="comparison-table">
                                <thead>
                                    <tr>
                                        <th>Feature</th>
                                        <th>Atropine</th>
                                        <th>Hyoscine (Scopolamine)</th>
                                    </tr>
                                </thead>
                                <tbody>
                                    <tr>
                                        <td><strong>Source</strong></td>
                                        <td><em>Atropa belladonna, Datura stramonium</em></td>
                                        <td><em>Hyoscyamus niger</em></td>
                                    </tr>
                                    <tr>
                                        <td><strong>Alkaloidal ester of</strong></td>
                                        <td>Tropic acid + Tropine</td>
                                        <td>Tropic acid + Scopine</td>
                                    </tr>
                                    <tr>
                                        <td><strong>CNS effect</strong></td>
                                        <td>Excitatory (low dose)<br>Excitation/Hallucination (high dose)</td>
                                        <td>Depressant (Amnesia, drowsiness)<br>Excitation/Hallucination (high dose)</td>
                                    </tr>
                                    <tr>
                                        <td><strong>Anticholinergic potency</strong></td>
                                        <td>More potent on heart, bronchial muscle, intestines</td>
                                        <td>More potent on eye and secretory glands</td>
                                    </tr>
                                    <tr>
                                        <td><strong>Duration</strong></td>
                                        <td>Longer</td>
                                        <td>Shorter</td>
                                    </tr>
                                    <tr>
                                        <td><strong>Anti-motion sickness</strong></td>
                                        <td>++</td>
                                        <td>+++</td>
                                    </tr>
                                </tbody>
                            </table>
                        </div>
                    </div>
                </section>

                <!-- Section 3: Atropine Substitutes -->
                <section class="content-section" id="substitutes">
                    <div class="section-header">
                        <div class="section-number">03</div>
                        <h2 class="section-title">
                            <span class="title-icon">üîÑ</span>
                            Atropine Substitutes
                        </h2>
                    </div>

                    <div class="content-card">
                        <p>Synthetic compounds introduced to produce more selective action on certain functions.</p>

                        <div class="grid grid-2">
                            <div class="grid-item">
                                <h4>Quaternary Compounds</h4>
                                <p><em>Incomplete oral absorption, poor CNS/eye penetration.</em></p>
                                <ul class="enhanced-list">
                                    <li class="list-item"><strong>Hyoscine butyl bromide:</strong> For esophageal/GI spasms.</li>
                                    <li class="list-item"><strong>Atropine methonitrate:</strong> For abdominal colics.</li>
                                    <li class="list-item"><strong>Ipratropium bromide:</strong> Inhalation for COPD/Asthma. Does not depress mucociliary clearance.</li>
                                    <li class="list-item"><strong>Tiotropium bromide:</strong> Long acting, high affinity for $M_1/M_3$. Once daily for COPD.</li>
                                    <li class="list-item"><strong>Propantheline:</strong> Antisecretory/antispasmodic.</li>
                                    <li class="list-item"><strong>Glycopyrrolate:</strong> Potent, rapidly acting. Used for preanaesthetic medication.</li>
                                </ul>
                            </div>
                            <div class="grid-item">
                                <h4>Tertiary Amines</h4>
                                <p><em>Better absorption, can penetrate CNS/eye.</em></p>
                                <ul class="enhanced-list">
                                    <li class="list-item"><strong>Dicyclomine:</strong> Direct smooth muscle relaxant + weak anticholinergic. Antispasmodic/Antiemetic.</li>
                                    <li class="list-item"><strong>Valethamate:</strong> Hastens cervical dilatation in labour.</li>
                                    <li class="list-item"><strong>Pirenzepine:</strong> Selective $M_1$ blocker. Inhibits gastric secretion (obsolete).</li>
                                    <li class="list-item"><strong>Oxybutynin:</strong> Vasicoselective. For urinary frequency/urgency.</li>
                                    <li class="list-item"><strong>Tolterodine:</strong> Relatively $M_3$ selective for overactive bladder.</li>
                                    <li class="list-item"><strong>Flavoxate:</strong> Urinary antispasmodic.</li>
                                    <li class="list-item"><strong>Darifenacin/Solifenacin:</strong> $M_3$ selective for urinary incontinence.</li>
                                </ul>
                            </div>
                        </div>

                        <h3>Mydriatics</h3>
                        <p>Used for refraction testing and fundoscopy. Shorter acting than atropine.</p>
                        <div class="table-responsive">
                            <table class="content-table">
                                <thead>
                                    <tr>
                                        <th>Drug</th>
                                        <th>Onset</th>
                                        <th>Duration</th>
                                        <th>Use</th>
                                    </tr>
                                </thead>
                                <tbody>
                                    <tr>
                                        <td><strong>Homatropine</strong></td>
                                        <td>45-60 min</td>
                                        <td>1-3 days</td>
                                        <td>Standard mydriatic</td>
                                    </tr>
                                    <tr>
                                        <td><strong>Cyclopentolate</strong></td>
                                        <td>30-60 min</td>
                                        <td>~1 day</td>
                                        <td>Cycloplegic refraction</td>
                                    </tr>
                                    <tr>
                                        <td><strong>Tropicamide</strong></td>
                                        <td>20-40 min</td>
                                        <td>3-6 hrs</td>
                                        <td>Fundoscopy (quickest)</td>
                                    </tr>
                                </tbody>
                            </table>
                        </div>
                    </div>
                </section>

                <!-- Section 4: Therapeutic Uses -->
                <section class="content-section" id="uses">
                    <div class="section-header">
                        <div class="section-number">04</div>
                        <h2 class="section-title">
                            <span class="title-icon">üíâ</span>
                            Therapeutic Uses
                        </h2>
                    </div>

                    <div class="content-card">
                        <ul class="enhanced-list">
                            <li class="list-item">
                                <span class="list-marker">1</span>
                                <span class="list-content"><strong>As antisecretory:</strong> Preanaesthetic medication (Glycopyrrolate/Atropine) to check secretions and prevent laryngospasm/vasovagal attack.</span>
                            </li>
                            <li class="list-item">
                                <span class="list-marker">2</span>
                                <span class="list-content"><strong>As antispasmodic:</strong> Intestinal/renal colic, nervous diarrhoea, IBS, pylorospasm, urinary frequency/urgency (Oxybutynin, Tolterodine).</span>
                            </li>
                            <li class="list-item">
                                <span class="list-marker">3</span>
                                <span class="list-content"><strong>Bronchial asthma/COPD:</strong> Ipratropium/Tiotropium inhalation. Effective in asthmatic bronchitis and COPD.</span>
                            </li>
                            <li class="list-item">
                                <span class="list-marker">4</span>
                                <span class="list-content"><strong>Mydriatic and Cycloplegic:</strong> For refraction testing (Cyclopentolate/Tropicamide) and treatment of iridocyclitis/keratitis (Atropine).</span>
                            </li>
                            <li class="list-item">
                                <span class="list-marker">5</span>
                                <span class="list-content"><strong>Cardiac vagolytic:</strong> Sinus bradycardia, partial heart block (Atropine).</span>
                            </li>
                            <li class="list-item">
                                <span class="list-marker">6</span>
                                <span class="list-content"><strong>Central uses:</strong> Parkinsonism (mild cases), Motion sickness (Hyoscine).</span>
                            </li>
                            <li class="list-item">
                                <span class="list-marker">7</span>
                                <span class="list-content"><strong>Antidote:</strong> For Anticholinesterase (organophosphate) poisoning and Mushroom poisoning (early type).</span>
                            </li>
                        </ul>
                    </div>
                </section>

                <!-- Section 5: Toxicity -->
                <section class="content-section" id="toxicity">
                    <div class="section-header">
                        <div class="section-number">05</div>
                        <h2 class="section-title">
                            <span class="title-icon">‚ò†Ô∏è</span>
                            Toxicity & Poisoning
                        </h2>
                    </div>

                    <div class="content-card">
                        <p>Belladonna poisoning occurs due to drug overdose or consumption of seeds/berries of <em>Datura</em>.</p>
                        
                        <div class="callout callout--danger">
                            <div class="callout-header">
                                <span class="callout-icon">üî•</span>
                                <h4 class="callout-title">Symptoms of Atropine Poisoning</h4>
                            </div>
                            <div class="callout-content">
                                <ul>
                                    <li>Dry mouth, difficulty swallowing.</li>
                                    <li>Dry, hot, flushed skin.</li>
                                    <li>Dilated pupil, photophobia, blurring.</li>
                                    <li>Excitement, psychosis, delirium, hallucinations.</li>
                                    <li>Hypotension, weak pulse, cardiovascular collapse, respiratory depression.</li>
                                </ul>
                            </div>
                        </div>

                        <h3>Treatment</h3>
                        <ul>
                            <li><strong>Gastric lavage:</strong> With tannic acid (if ingested).</li>
                            <li><strong>Supportive:</strong> Dark quiet room, cold sponging (for fever), diazepam (for convulsions).</li>
                            <li><strong>Specific Antidote:</strong> <strong>Physostigmine</strong> ($1-3 \text{ mg}$ s.c. or i.v.). It antagonises both central and peripheral effects. Neostigmine does not block central effects.</li>
                        </ul>
                        
                        <p><strong>Contraindications:</strong> Narrow angle glaucoma, prostatic hypertrophy (caution).</p>
                    </div>
                </section>

                <!-- Section 6: Ganglionic Drugs -->
                <section class="content-section" id="ganglionic-drugs">
                    <div class="section-header">
                        <div class="section-number">06</div>
                        <h2 class="section-title">
                            <span class="title-icon">üö¨</span>
                            Drugs Acting on Autonomic Ganglia
                        </h2>
                    </div>

                    <div class="content-card">
                        <p>Acetylcholine is the primary excitatory neurotransmitter in both sympathetic and parasympathetic ganglia (Nicotinic $N_N$ receptors).</p>

                        <h3>Nicotine</h3>
                        <p>Principal alkaloid in tobacco. Stimulates both sympathetic and parasympathetic ganglia (low dose) followed by blockade (high dose).</p>
                        <ul>
                            <li><strong>Uses:</strong> Smoking cessation (Nicotine transdermal patch, chewing gum).</li>
                            <li><strong>Related drugs:</strong> Varenicline (Partial agonist of $\alpha 4 \beta 2$ NRs), Bupropion (Antidepressant).</li>
                        </ul>

                        <h3>Ganglion Blocking Agents</h3>
                        <p>Competitive antagonists (e.g., Hexamethonium, Trimethaphan, Mecamylamine). They block both sympathetic and parasympathetic ganglia.</p>
                        
                        <div class="table-responsive">
                            <table class="content-table">
                                <thead>
                                    <tr>
                                        <th>Organ</th>
                                        <th>Dominant Tone</th>
                                        <th>Effect of Blockade</th>
                                    </tr>
                                </thead>
                                <tbody>
                                    <tr>
                                        <td>Heart</td>
                                        <td>Parasympathetic</td>
                                        <td>Tachycardia</td>
                                    </tr>
                                    <tr>
                                        <td>Blood vessels</td>
                                        <td>Sympathetic</td>
                                        <td>Vasodilatation, Hypotension</td>
                                    </tr>
                                    <tr>
                                        <td>Iris</td>
                                        <td>Parasympathetic</td>
                                        <td>Mydriasis</td>
                                    </tr>
                                    <tr>
                                        <td>Intestine/Bladder</td>
                                        <td>Parasympathetic</td>
                                        <td>Constipation, Urinary retention</td>
                                    </tr>
                                </tbody>
                            </table>
                        </div>
                        <p><em>Note: Ganglion blockers are obsolete clinically due to multiple side effects.</em></p>
                    </div>
                </section>

                <!-- Problem Directed Study -->
                <section class="content-section" id="problem-study">
                    <div class="section-header">
                        <div class="section-number">07</div>
                        <h2 class="section-title">
                            <span class="title-icon">üß©</span>
                            Problem Directed Study
                        </h2>
                    </div>

                    <div class="content-card">
                        <div class="callout callout--warning">
                            <div class="callout-header">
                                <span class="callout-icon">‚ùì</span>
                                <h4 class="callout-title">Case Study 8.1</h4>
                            </div>
                            <div class="callout-content">
                                <p>An elderly male aged 74 years was brought to the hospital since he had not passed urine for the past 24 hours and had severe pain in lower abdomen. On examination there was a bulge in the pubic region due to full urinary bladder. On catheterization, he passed 1.5 L urine and the pain was relieved.</p>
                                <p>He gave the history of having difficulty in passing urine, poor stream, frequent urge to urinate and post-void dribbling for the last 3 years. Over the past few days he had been experiencing episodes of vertigo for which he was prescribed a medicine that he was taking for 2 days. Examination of the prescription revealed that he was taking tab. Dimenhydrinate 50 mg 3 times daily.</p>
                                <p><strong>(a) Could there be any relationship between the anti-vertigo medication and the episode of acute urinary retention?</strong></p>
                                <p><em>(See Appendix-1 for solution)</em></p>
                            </div>
                        </div>
                    </div>
                </section>

            </main>

            <nav class="document-nav">
                <div class="nav-container">
                    <a href="topic-07-ans-general.html" class="nav-button nav-button--large nav-button--previous">
                        <div class="nav-label">Previous</div>
                        <div class="nav-title">ANS: General Considerations</div>
                    </a>
                    
                    <div class="document-progress">
                        <div class="progress-indicator">
                            <span>9</span>
                            <span class="progress-separator">/</span>
                            <span>13</span>
                        </div>
                        <div class="progress-bar-container">
                            <div class="progress-bar-fill" style="width: 69.2%;"></div>
                        </div>
                        <div class="progress-label">Topic Progress</div>
                    </div>
                    
                    <a href="topic-10-adrenergic.html" class="nav-button nav-button--large nav-button--next">
                        <div class="nav-label">Next</div>
                        <div class="nav-title">Adrenergic Transmission</div>
                    </a>
                </div>
            </nav>
        </article>
    </div>
</div>

<!-- Lightbox Modal -->
<div class="lightbox-modal" id="lightbox-modal" role="dialog" aria-modal="true" aria-label="Image viewer" hidden>
    <div class="lightbox-backdrop"></div>
    <div class="lightbox-content">
        <button class="lightbox-close" aria-label="Close image viewer">√ó</button>
        <img class="lightbox-image" src="" alt="">
        <p class="lightbox-caption"></p>
    </div>
</div>

<script src="../js/theme.js"></script>
<script src="../js/navigation.js"></script>
<script src="../js/interactions.js"></script>
</body>
</html>
